Skip to content

On Monday, FDA announced two warning letters issued to makers of topical CBD products labeled as OTC drugs.  Amidst a backdrop of facility inspections that revealed significant good manufacturing compliance concerns, the most important takeaways in this round of CBD
Continue Reading FDA Enforcement: There’s Nothing Inactive About CBD and “FDA Registered” Is Misleading

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:

CBD

FTC Approves Final Administrative Consent Orders against Sellers of Deceptively Marketed CBD Products

Following a public comment period, the Federal Trade Commission has approved final administrative


Continue Reading CBD and Hemp Legal and Regulatory Roundup – March 5, 2021

As 2020 drew to a close and Congress scrambled to reach a deal to continue funding the federal government, tucked in amidst the 2124 pages of the 2021 Appropriations Bill is a new power for the FTC:  civil penalty authority
Continue Reading ICYMI: The FTC Has Civil Penalty Authority Relative To COVID-Related Advertising